Events & News



Meeting with our CEO Dr. Max Sonnleitner at BIO-EUROPE SPRING 2020 in Paris discuss cooperation possibilities


GENSPEED Biotech and axiVEND Announce a Collaboration Agreement

“The platform itself is very promising, leveraging simple microfluidic consumables and associated ease of use,” said Claude Dufresne, axiVEND CEO. “This platform gives us the fastest and best probability of success to bring novel multiplex test ideas to the market

Read more›

Virogates A/S  counts on GENSPEED Technology

Virogates has commenced a partnership to codevelop a product based on a combination of ViroGates’ suPARnostic and GENSPEED Biotech’s unique point of care testing platform to develop a finger prick test to analyse for suPAR and C Reactive Protein  in less than 10 minutes

Read more